IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CMPX

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents35.4555.1730.6446.2122.8641.0543.4836.8019.4023.6724.2330.4319.2827.0334.9516.4826.24136.38144.5125.51
Short-term Investments144.43139.52178.26173.6878.0971.5983.2498.60126.82132.58128.23133.28149.47148.14151.66104.12105.78------
Total Current Assets180.89195.69209.82221.12106.20124.15132.75141.14153.55158.61153.88166.58175.27183.60194.79122.55134.54140.28147.1028.57
Property, Plant & Equipment0.320.170.100.120.130.230.350.490.590.740.901.051.201.371.571.711.852.142.241.44
Total Non-current Assets*9.289.489.7710.1410.507.317.658.012.072.532.993.453.914.374.855.285.716.286.656.33
Total Assets190.17205.17219.59231.26116.70131.45140.40149.15155.61161.14156.88170.04179.18187.98199.65127.84140.26146.56153.7634.90
Accounts Payable2.910.911.593.102.601.582.250.961.190.854.092.310.721.133.382.766.530.260.870.87
Total Current Liabilities16.1310.2813.9712.4113.8614.908.874.439.513.897.809.129.7011.1916.179.5810.889.3310.637.68
Long-term Debt------------------------------------0.000.00
Total Non-current Liabilities*8.008.428.839.239.636.276.306.320.000.190.540.871.201.521.842.142.442.743.053.33
Total Liabilities24.1218.7022.8021.6523.4921.1715.1710.759.514.088.349.9910.9012.7118.0111.7213.3312.0713.6811.01
Retained Earnings(474.64)(449.49)(431.17)(415.46)(401.20)(381.32)(364.68)(349.65)(339.17)(326.10)(315.31)(301.89)(291.93)(280.65)(272.81)(261.22)(249.24)(240.75)(233.59)(220.61)
Total Stockholder Equity166.05186.47196.79209.6193.21110.28125.23138.40146.10157.06148.54160.04168.29175.27181.64116.12126.93134.49140.0823.89
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue----0.000.000.00--0.000.000.85--0.000.000.00--------------
Research & Development--13.3913.6712.8316.4213.0513.03--------------------------
Selling, General & Admin7.406.914.322.994.654.913.543.634.723.252.963.103.113.072.962.813.132.773.432.70
Total Operating Expenses26.9820.3017.9915.8221.0717.9716.5712.2415.9012.7715.3911.9313.349.7112.8912.608.997.1813.005.85
Operating Income(26.98)(20.30)(17.99)(15.82)(21.07)(17.97)(16.57)(12.24)(15.04)(12.77)(15.39)(11.93)(13.34)(9.71)(12.89)(12.60)(8.99)(7.18)(13.00)(5.85)
Interest Expense----------------------------0.000.000.000.000.040.08
Pretax Income----------(16.63)----(13.08)(10.79)(13.41)(9.96)(11.28)(7.84)(11.59)(11.97)(8.49)(7.16)(12.99)(5.97)
Tax Provision----------0.00----0.000.000.000.000.000.000.000.000.000.00(0.01)0.00
Net Income(25.15)(18.32)(15.72)(14.26)(19.88)(16.63)(15.03)(10.48)(13.08)(10.79)(13.41)(9.96)(11.28)(7.84)(11.59)(11.97)(8.49)(7.16)(12.98)(5.97)
Basic EPS(0.13)(0.10)(0.08)(0.08)(0.14)(0.12)(0.10)(0.08)(0.10)(0.08)(0.10)(0.08)(0.09)(0.06)(0.10)(0.12)(0.08)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(14.74)(17.27)(13.25)(10.85)(11.83)(13.21)(9.16)(11.05)(10.75)(13.89)(12.35)(5.92)(10.11)(12.23)(10.64)(10.94)(4.60)(7.94)(4.66)(3.46)
Capital Expenditures0.180.080.000.010.000.020.000.040.00--0.010.010.010.000.050.03(0.06)0.190.780.37
Free Cash Flow*(14.91)(17.35)(13.25)(10.86)(11.83)(13.23)(9.16)(11.09)(10.75)--(12.36)(5.93)(10.12)(12.23)(10.69)(10.97)(4.54)(8.14)(5.44)(3.82)
Investing Cash Flow(4.98)38.43(3.38)(95.16)(6.36)11.5915.3729.026.48(4.10)6.3117.05(0.67)4.27(46.65)1.18(105.54)(0.19)(0.78)(0.37)
Financing Cash Flow0.003.371.06129.360.00(0.81)(0.09)-0.000.0017.43(0.16)0.023.030.0475.750.010.000.00124.24(1.87)
← Scroll for more columns →

* Derived from reported values